在炎症性肠病中乳腺的血清水平 (MFGE8)
Kamil Kozioł1, Danuta Owczarek2, Dorota Cibor2
1Department of Gastroenterology and Hepatology, Jagiellonian University Medical College, Kraków, Poland. kknsno@gmail.com.
Folia medica Cracoviensia
|February 4, 2024
概括
血清乳腺素 (MFGE8) 水平在活性性结肠炎 (UC) 中升高,与CRP和纤维素原等炎症标志物相反相关. 这些发现表明MFGE8可能是活性UC炎症的生物标志物.
科学领域:
- 胃肠病学 胃肠病学
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 包括性结肠炎 (UC) 和克罗恩病 (CD).
- 生物标志物对于评估IBD活动和指导治疗至关重要.
- 乳腺素 (MFGE8) 是一种糖蛋白,在炎症和组织修复中具有潜在的作用.
研究的目的:
- 为了评估IBD患者的血清乳腺素 (MFGE8) 水平.
- 为了确定MFGE8水平与疾病活性之间的相关性.
- 调查MFGE8和生物化学炎症标志物之间的关系.
主要方法:
- 从UC (n=50),CD (n=68) 和健康对照组 (n=29) 的成年患者收集了血清样本.
- 测量了MFGE8度,并在各组之间进行了比较.
- 分析了MFGE8,C反应蛋白 (CRP),白细胞计数 (WBC),纤维素和疾病活性指数之间的相关性.
主要成果:
- 与对照组相比,UC患者的MFGE8水平显著更高.
- 与对照组相比,活跃的UC患者表现出较高的MFGE8水平.
- 在活跃的UC患者中,MFGE8与CRP,WBC和纤维素原显著反相关.
结论:
- 在活跃的性结肠炎中,血清MFGE8水平升高.
- MFGE8水平与活跃UC中的关键炎症标志物相反相关.
- MFGE8可能作为UC活跃炎症的潜在生物标志物,与CD不同.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
244
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
244
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
186
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
186
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137